Cited by 109Chronic Kidney Disease and DiabetesDialysis and Renal Disease ManagementAcute Kidney Injury Research

Incidence of chronic kidney disease among adults with diabetes, 2015-2020

Open access
Tuttle, Katherine R., Jones, Cami R., Daratha, Kenn B., Koyama, Alain K., Nicholas, Susanne B., Alicic, Radica Z., Duru, O. Kenrik, Neumiller, Joshua J. +3 more·2022·New England Journal of Medicine

Abstract

The prevalence of kidney failure warranting dialysis or transplantation more than doubled between 2000 and 2019 to nearly 800,000 persons in the United States, with diabetes as the leading cause in 47% of those affected.1,2 The incidence of chronic kidney disease (CKD) among patients with diabetes is unknown, yet such data are vital for identifying high-risk populations, determining the effectiveness of interventions, and assessing the effects on health care delivery and public health responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc2207018

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced eGFR without albuminuria has been frequently reported in type 1 and type 2 diabetes and is becoming more common over time as the prevalence of diabetes increases in the U.S.

    “Reduced eGFR without albuminuria has been frequently reported in type 1 and type 2 diabetes and is becoming more common over time as the prevalence of diabetes increases in the U.S. (2,3,18,20,21).”

    From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [3]

    In “TO THE EDITOR” (page unavailable), the paper treats reduced eGFR as a CKD criterion independent of albuminuria and notes a large increase in diabetes prevalence. It does not report how frequently reduced eGFR occurs without albuminuria in type 1 or type 2 diabetes, or show that this phenotype is becoming more common. Its measured outcome—overall CKD incidence among adults with diabetes—declined from 2015–2016 to 2019–2020. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • The incidence of CKD in people with diabetes has decreased over the last decade but remains high in the U.S. and around the world.

    “The incidence of CKD in people with diabetes has decreased over the last decade but remains high in the U.S. (3) and around the world (7).”
  • CKD attributed to diabetes in adults occurs in 20-40% of people with diabetes.

    “In this section, the focus is on CKD attributed to diabetes in adults, which occurs in 20-40% of people with diabetes (1)(2)(3)(4).”

    From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [3]

    The “To the Editor” section reports CKD incidence among adults with diabetes in two U.S. health care systems, not the proportion of people with diabetes who have CKD. Searches for the 20–40% figure and CKD prevalence found no passage in our copy supporting that estimate; no page number is available. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [4]International Diabetes Federation. IDF diabetes atlas 10th ed. 2021 (https://diabetesatlas.org/atlas/tenth-edition/).

Cited by

Sorted by citations

Authors
Tuttle, K. R., Jones, C. R., Daratha, K. B., Koyama, A. K., Nicholas, S. B., Alicic, R. Z., Duru, O. K., Neumiller, J. J., Norris, K. C., Ríos Burrows, N., & Pavkov, M. E.
Affiliations
  • Providence Health, Spokane, WA
  • Centers for Disease Control and Prevention (US)
  • University of California, Los Angeles (US)
  • Centers for Disease Control and Prevention, Atlanta, GA
Venue
New England Journal of Medicine
Published
2022-10-13
Volume
387
Issue
15
Pages
1430-1431
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4304809004
Cited by
109
References
4
Citations by year
2026: 18 · 2025: 33 · 2024: 34 · 2023: 22 · 2022: 2
FWCI
14.44
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
Centers for Disease Control and Prevention (75D301-21-P-12254)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
chronic kidney disease, diabetes mellitus, incidence, renal failure, dialysis, kidney transplantation, adults
MeSH terms
Adult, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Risk Factors, Incidence, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review